From: Neuroendocrine liver metastasis from the small intestine: Is surgery beneficial for survival?
Total n = 123/117a | ||
---|---|---|
Gender | Male | 71 (57.7%) |
Female | 52 (42.3%) | |
Localization | Jejunum | 22 (17.9%) |
Ileum | 101 (82.1%) | |
Grading | G1 | 94 (76.4%) |
G2 | 29 (23.6%) | |
Primary tumors | Solitary | 83 (67.5%) |
Multiple | 40 (32.5%) | |
Age (range) | 62 (36; 87) | |
Stage I–III A | N0, M0 | 35/117a (29.9%) |
Stage III B | N1, M0 | 1/117a (0.9%) |
Stage IV | N0/N1, M1 | 81/117a (69.2%) |
No liver surgery (surveillance-Group 1) | 53/81 (65.4%) | |
Liver resection ≤ 1 segment (Group 2a) | 17/81 (21.0%) | |
Liver resection > 1 segment (Group 2b) | 8/81 (9.9%) | |
Liver transplantation | 3/81 (3.7%)b |